Publications, Pharmaceutical

An Eye on the Future of Preservative-Free Drops

In this article, Alexandra Ritter, Head of Regulatory Affairs and Combination Products, and Matthias Birkhoff, Vice-President Business Development, both at Aptar Pharma, discuss the value that Aptar Pharma’s regulatory support and services add to the filing process of a new eye care development, the challenges of administering a wider range of medications via topical eye drops and the benefits of preservative-free multidose ophthalmic drug-device combination products.

For more information on ONdrugDelivery.

 

Download Publication
Author(s): Alexandra Ritter Matthias Birkhoff
15 Mar 2022

Learn more about Ophthalmic Squeeze Dispenser

Find Out More About OSD

This Might Also Be of Interest

18 Dec 2023

Elevating Medication Adherence and Clinical Outcomes with Connected Drug Delivery

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
13 Mar 2023

Moving Towards Greater Recyclability in Drug Delivery – Sustainable Solutions b...

Webinars, Pharmaceutical, Sustainability, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
14 Dec 2022

Building Digital Solutions To Meet The Unique Therapeutic Needs of Patients

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions

Read More
9 Nov 2022

Sustainability Measures Are the Key to Meeting ESG Commitments

Publications, Pharmaceutical, Sustainability, Market Insights, Product Solutions

Read More
1 2 3 … 6

Request Access

Close

Requesting access to An Eye on the Future of Preservative-Free Drops.

  • This field is for validation purposes and should be left unchanged.

How Can We Help?

Back To Top